First Tracks Biotherapeutics Inc (TRAX)

NASDAQ · Biotechnology

44.82
+1.22 (+2.80%)
Updated Aug 18, 2:36 PM ET
AI Rating
Hold
Overall Score
53
Trend
75
Momentum
64
Risk
4

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Apr 6, 2026 92 sessions Aug 14, 2026

AI Analysis

First Tracks Biotherapeutics Inc is trading at $44.82, up 2.80% on the session. The 50 day average sits at $30.35 and the 200 day at $n/a, which puts the stock in a mixed technical position. RSI is at 60.6, which reads as strong, and MACD is bearish crossover. Volume is below average.

The nearest support is around $34.72 with resistance near $49.58, so that band frames the current range. Average daily movement is roughly $3.58, or about 8.0% of the share price, which is what any stop placement has to allow for. The overall health score of 53 out of 100 combines a trend score of 75, momentum of 64 and a risk score of 4.

Technical indicators

RSI (14)
60.6
strong
MACD
4.254
bearish crossover
SMA 20
43.09
SMA 50
30.35
SMA 200
--
unknown
ATR (14)
3.58
avg daily range
Support
34.72
Resistance
49.58
Volume vs 20d
0.59x
below average
Volatility
92.8%
annualised
1 month
+21.62%
3 months
+142.51%

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.